Expensive today but cheaper tomorrow: lifetime costs of an active middle ear implant compared to alternative treatment options.

Autor: Krohn M; Chair of General Business Administration and Health Care Management, University of Greifswald, Greifswald, Germany. markus.krohn@uni-greifswald.de., Kiesewetter K; MED-EL Medical Electronics, Innsbruck, Austria., Buchholz A; Department of Otolaryngology, Hannover Medical School, Hannover, Germany., Schlick B; MED-EL Medical Electronics, Innsbruck, Austria., Busch S; Department of Otolaryngology, Hannover Medical School, Hannover, Germany., Lenarz T; Department of Otolaryngology, Hannover Medical School, Hannover, Germany., Lesinski-Schiedat A; Department of Otolaryngology, Hannover Medical School, Hannover, Germany., Maier H; Clinic for Laryngology, Rhinology and Otology, Hannover Medical School, Hannover, Germany., Batsoulis C; MED-EL Medical Electronics, MED-EL Research Center, Hannover, Germany., Urban M; MED-EL Medical Electronics, Innsbruck, Austria., Flessa S; Chair of General Business Administration and Health Care Management, University of Greifswald, Greifswald, Germany.

Publikováno v: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.

Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons

Autor: Schlick, B., Flucher, B.E. ^⁎, Obermair, G.J. ^⁎

Publikováno v: In Neuroscience 2010 167(3):786-798

EE409 The Costs of Unaddressed Hearing Loss as a Basis for Cost-Effectiveness Analyses

Autor: Schwarz, C. ¹, Dejaco, T. ², Hoch, A. ², Kiesewetter, K. ¹, Rose-Eichberger, K. ², Scandurra, F. ², Schlick, B. ², Urban, M. ²

Publikováno v: In Value in Health December 2023 26(12) Supplement:S129-S130

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.

Autor: Schlick B; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA., Shields MD; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA., Marin-Acevedo JA; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA., Patel I; Department of Public Health, University of South Florida, 4202 E Fowler Ave, Tampa, FL, 33620, USA., Pellini B; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12902 Magnolia Dr, GME Office, Tampa, FL, 33612, USA. Bruna.Pellini@moffitt.org.; Department of Thoracic Oncology, Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr, CSB 6-THOR PROG, Tampa, FL, 33612, USA. Bruna.Pellini@moffitt.org.

Publikováno v: Current treatment options in oncology [Curr Treat Options Oncol] 2022 Aug; Vol. 23 (8), pp. 1104-1120. Date of Electronic Publication: 2022 Jun 18.